BELLINO, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 4.779
NA - Nord America 1.821
EU - Europa 1.052
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 48
OC - Oceania 7
Totale 8.035
Nazione #
HK - Hong Kong 3.393
US - Stati Uniti d'America 1.744
SG - Singapore 680
IT - Italia 465
CN - Cina 233
BR - Brasile 194
VN - Vietnam 192
RU - Federazione Russa 168
DE - Germania 122
BD - Bangladesh 81
FR - Francia 73
FI - Finlandia 49
IN - India 46
CA - Canada 36
GB - Regno Unito 34
MX - Messico 27
NL - Olanda 27
KR - Corea 24
PL - Polonia 24
IE - Irlanda 19
JP - Giappone 19
ZA - Sudafrica 16
AR - Argentina 15
CZ - Repubblica Ceca 15
ES - Italia 14
TR - Turchia 13
SE - Svezia 12
PK - Pakistan 10
ID - Indonesia 9
IQ - Iraq 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
CO - Colombia 8
EC - Ecuador 8
MY - Malesia 8
EG - Egitto 7
CL - Cile 6
LB - Libano 6
LU - Lussemburgo 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
JM - Giamaica 5
MA - Marocco 5
PH - Filippine 5
UA - Ucraina 5
DZ - Algeria 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
VE - Venezuela 4
CH - Svizzera 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
GF - Guiana Francese 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
SN - Senegal 2
TN - Tunisia 2
AT - Austria 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
CV - Capo Verde 1
ET - Etiopia 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.952
Città #
Hong Kong 3.390
San Jose 359
Singapore 350
Dallas 265
Ashburn 193
Milan 188
Munich 94
Beijing 77
Council Bluffs 73
Ho Chi Minh City 69
Los Angeles 68
Rome 66
Boardman 64
Lauterbourg 59
New York 55
Santa Clara 46
Hanoi 44
Turku 43
The Dalles 40
Moscow 33
Chandler 30
São Paulo 22
Warsaw 22
Montreal 20
Princeton 19
Dublin 17
Denver 16
Turin 16
Woodbridge 16
Amsterdam 15
Figino 15
Frankfurt am Main 15
Memphis 15
Tokyo 15
Buffalo 13
Mexico City 13
Naples 13
Orem 13
Brno 12
Houston 12
Chicago 11
Phoenix 11
Stockholm 11
Bologna 10
Da Nang 10
Poplar 10
Boston 9
Palermo 9
Querétaro 9
San Francisco 9
Seoul 9
Tashkent 9
Brooklyn 8
Chennai 8
Haiphong 8
Johannesburg 8
Toronto 8
Atlanta 7
Florence 7
Jacksonville 7
New Delhi 7
Rio de Janeiro 7
Washington 7
Beirut 6
Belo Horizonte 6
Campinas 6
Dudelange 6
Hải Dương 6
Mumbai 6
Pune 6
Ann Arbor 5
Manchester 5
Nuremberg 5
Salerno 5
Ankara 4
Bari 4
Brasília 4
Cairo 4
Curitiba 4
Guayaquil 4
Helsinki 4
Jeddah 4
Juneau 4
London 4
Monteforte Irpino 4
Paris 4
Porto Alegre 4
Santiago 4
Seattle 4
Venice 4
Wilmington 4
Amman 3
Augusta 3
Baghdad 3
Cagliari 3
Can Tho 3
Chaguanas 3
Charlotte 3
Columbus 3
Falkenstein 3
Totale 6.261
Nome #
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 939
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 529
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 459
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 435
[Diagnosis of cardiovascular involvement in Fabry disease] 411
Subsequent Safe Pregnancy with Cesarean Delivery in a Patient with a History of Peripartum Takotsubo Syndrome Complicated by Cardiogenic Shock 285
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 246
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 166
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 160
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 154
Noninvasive assessment of left ventricular performance using pressure–volume loops, blood propulsion and strain tensors: results from the World Alliance of Societies of Echocardiography study 138
Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 136
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 130
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 124
Isolated Valve Amyloid Deposition in Aortic Stenosis: Potential Clinical and Pathophysiological Relevance 120
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 117
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 114
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 112
Caged-Ball Mitral Prosthesis Explanted After 50 Years 110
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes 108
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 107
Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19 107
From Planning to Practice: Impact of Achieved Proximal Sealing Zone in Endovascular Aneurysm Repair (EVAR) 105
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 100
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome 97
Bioprosthetic Valve Fracture After TAVR Complicated by Balloon Rupture: Bail-Out TAVR in TAVR in SAVR 93
Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? 93
Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of “cellular and molecular biology of the heart” and “cardiac rehabilitation and cardiovascular prevention” of the Italian Society of Cardiology (SIC) 91
Reply 88
[Cardiovascular management of patients with chronic myeloid leukemia treated with BCR-ABL tyrosine kinase inhibitors: it is time for a shared management] 88
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model 88
Obstructive Hypertrophic Cardiomyopathy and Takotsubo Syndrome: How to Deal With Left Ventricular Ballooning? 87
Exercise Pulmonary Hypertension in Heart Valve Disease 85
Bicuspid Aortic Valve Registry of the Italian Society of Echocardiography and Cardiovascular Imaging (REgistro della valvola aortica bicuspide della società italiana di ECocardiografia e CArdiovascular imaging): Rationale and Study Design 84
Novel targets and strategies addressing residual cardiovascular risk in post-acute coronary syndromes patients 83
Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe 78
Normal Values of Left Atrial Size and Function and the Impact of Age: Results of the World Alliance Societies of Echocardiography Study 78
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report 76
Clinical Outcomes in Patients With Bicuspid Aortic Valves and Ascending Aorta ≥50 mm Under Surveillance 75
How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO registry 70
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand? 70
Unusual, Radical Treatment of Type A Aortic Dissection: A Case Report 70
Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis 69
Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome 68
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma 63
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 63
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 62
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry 57
Aortopathy and regurgitation in bicuspid valve patients increase the risk of aortopathy in relatives 57
Cardiovascular Mortality in Takotsubo Syndrome 56
Prevalence and Prognostic Significance of Right Ventricular Dysfunction in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement 53
Imaging Cardiovascular Emergencies: Real World Clinical Cases 50
Ventricular Septal Defect Complicating Inferior Acute Myocardial Infarction: A Case of Percutaneous Closure 49
Comparison of mortality in primary and secondary Takotsubo cardiomyopathy with severe left ventricular dysfunction: reply 49
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by John E Madias 48
Invasive and Non-invasive Assessment of Non-culprit Coronary Lesions in Patients with ST-segment Elevation Myocardial Infarction 47
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by Chang et al 43
Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair 39
A Quali-Quantitative Analysis of Biosensing and Biotransducing Systems for Cardiovascular Monitoring: Pacemakers Active and Passive Stress 38
Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver 37
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial 36
Spontaneous coronary artery dissection: do we need different tailored strategies? 33
The Role of Stress Echocardiography in Valvular Heart Disease 33
Role of Mechanical Circulatory Support in Complex High-Risk and Indicated Percutaneous Coronary Intervention: Current Indications, Device Options, and Potential Complications 33
Predictors of thromboembolic events in Takotsubo syndrome: reply 32
The Right Heart-Pulmonary Circulation Unit and Left Heart Valve Disease 14
Totale 8.035
Categoria #
all - tutte 22.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 1 0 3 3 2 2 2 15
2022/2023111 5 11 5 11 17 21 2 9 21 2 7 0
2023/2024247 4 15 16 4 13 27 5 10 0 15 14 124
2024/2025859 23 2 17 30 21 57 150 32 122 89 172 144
2025/20266.645 955 1.575 1.400 275 496 153 466 127 231 395 197 375
2026/202793 93 0 0 0 0 0 0 0 0 0 0 0
Totale 8.035